title: Feline Calcium Oxalate Urolithiasis: Risk factors and rational treatment approaches.
abstract: Uroliths occur commonly in the bladder and/or urethra of cats and can be lifethreatening if urethral obstruction occurs. Calcium oxalate accounts for 40-50% of urocystoliths and these stones are not amenable to medical dissolution; therefore, removal by surgery or minimally invasive techniques is required if uroliths must be treated. Medical protocols for prevention involve decreasing urine saturation for minerals that form uroliths.
  
  
  
  Formation of uroliths is not a disease, but rather a complication of several disorders. Some disorders can be identified and corrected (such as infection-induced struvite urolith formation); others can be identified but not corrected (such as idiopathic hypercalcemia). In most cats with calcium oxalate urolith formation the underlying etiopathogenesis is not known. A common denominator of all these disorders is that they can from time to time create oversaturation of urine with one or more crystal precursors, resulting in formation of crystals.
  
  
  
  In order to develop rational and effective approaches to treatment, abnormalities that promote urolith formation must be identified, with the goal of eliminating or modifying them. It is important, therefore, to understand several basic concepts associated with urolithiasis and the factors that promote urolith formation that may be modified with medical treatment; for example, the state of urinary saturation, modifiers of crystal formation, potential for multiple crystal types, and presence of bacterial infection or urinary obstruction.
authors: Department of Small Animal Medicine and Surgery, College of Veterinary Medicine, The University of Georgia, 501 D. W. Brooks Drive, Athens, GA 30602, USA jbartges@gmail.com.
authors: Joseph W
authors: JW
authors: Bartges
mesh_terms: D000818:Animals; D002129:Calcium Oxalate / Q000378:metabolism*; D002371:Cat Diseases / Q000378:metabolism* / Q000628:therapy*; D002415:Cats; D012307:Risk Factors; D052878:Urolithiasis / Q000378:metabolism / Q000628:therapy / Q000662:veterinary*
chemical_list: D002129:Calcium Oxalate